WeVote
Log In

Bill

Bill

S 3989

Requires hepatitis C virus testing of newborns

2025 Regular Session Introduced by Kevin Parker

Bill S 3989 mandates hepatitis C testing for all newborns, ensuring early detection and follow-up care to improve health outcomes and reduce long-term complications.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 3989

Summary of Bill S 3989: Requires Hepatitis C Virus Testing of Newborns

Purpose and Intent

Bill S 3989 aims to mandate hepatitis C virus (HCV) testing for newborns in order to identify and address potential infections early in life. The primary goal is to improve health outcomes for affected infants and reduce the long-term health complications associated with untreated hepatitis C.

Key Provisions

  • Mandatory Testing: The bill requires that all newborns be tested for hepatitis C before they are discharged from the hospital.
  • Reporting Requirements: Hospitals and healthcare providers will be required to report the results of HCV tests to the appropriate health authorities.
  • Follow-Up Care: The bill emphasizes the importance of follow-up care for infants who test positive for HCV, ensuring that they receive appropriate medical attention and treatment.
  • Public Awareness Campaign: The legislation may include provisions for public awareness initiatives to educate parents and healthcare providers about hepatitis C and the importance of testing.

Who Would Be Affected

  • Newborns: Infants born in hospitals will be directly affected, as they will undergo mandatory HCV testing.
  • Parents and Caregivers: Families will need to be informed about the testing process and the implications of test results.
  • Healthcare Providers: Hospitals and medical staff will be responsible for implementing the testing protocol and ensuring compliance with reporting requirements.
  • Public Health Authorities: State and local health departments will be involved in tracking and managing reported cases of hepatitis C among newborns.

Procedural Aspects

  • Introduced Date: The bill was introduced on January 31, 2025.
  • Current Status: As of now, the bill has been referred to the Health Committee for further consideration.
  • Related Legislation: This bill is part of a series of related bills from prior sessions (S 1816, S 4871, S 3465, S 4553, S 4790, S 5768), indicating ongoing legislative interest in addressing hepatitis C testing and treatment.

Conclusion

Bill S 3989 represents a proactive approach to tackling hepatitis C among newborns, aiming to facilitate early detection and intervention. By mandating testing and establishing follow-up care protocols, the bill seeks to improve health outcomes for infants and reduce the long-term impact of hepatitis C. The bill is currently under consideration by the Health Committee, and its progress will be closely monitored by stakeholders in public health and pediatric care.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.